Lord’s marks collaboration with CMET to develop AI-based breast cancer detection device | India News

Lord’s Mark Industries Limited has entered into a technology transfer agreement with the Center for Materials for Electronic Technology (CMET) to develop an AI-powered, radiation-free breast screening wearable device for early detection of breast cancer.India ranks third globally for new breast cancers after China and the US, with the disease accounting for more than 26% of all female cancers in the country. The global breast cancer market was valued at USD 4,882.14 million in 2024 and is expected to reach USD 12,880.85 million by 2035 at a CAGR of 9.22%1. Grand View Research 2 highlights diagnostics as the dominant segment driven by demand for early detection, while Future Market Insights estimates the screening and diagnostics market at USD 5.05–5.86 billion in 2025, which is expected to reach USD 10.5–11.36 billion by 2033–2035.The wearable integrates high-precision thermal sensors with AI-powered temperature mapping to detect early-stage abnormalities in a non-invasive, radiation-free manner. The partnership combines CMET’s R&D expertise with Lord’s Mark’s manufacturing scale and distribution power, accelerating indigenous med-tech innovation.Key Features and Benefits

The device represents a significant advance over traditional mammography by eliminating radiation exposure and discomfort, expanding access beyond hospital settings, and providing reliable AI-powered detection insights.Through this initiative, Lord’s Mark positions itself at the forefront of scalable preventive diagnostics in India, reinforcing its long-term commitment to advance accessible, AI-led healthcare solutions.Sachidananda Upadhyay, Managing Director, Lord’s Mark Industries Limited, commented on the partnership with CMET: “This collaboration marks a defining step in our journey to create globally competitive, indigenous healthcare technologies. By integrating the scientific expertise of CMET with the manufacturing power of Lord’s Mark, we are enabling a new paradigm in preventive diagnostics – non-invasive, AI-driven and truly accessible. Our vision is to reduce barriers to early detection and empower women across India through safe, smart screening solutions. This is not just a product initiative; It is the promise of scalable, impact-led healthcare innovation.With this initiative, Lord’s Mark Industries Limited said it is strengthening its focus on technology-led healthcare manufacturing with an emphasis on intelligent, inclusive and impact-driven solutions designed to make early detection safer, easier and more accessible. The company plans to commercialize the product for large-scale breast cancer screening in India and over time expand its availability to international markets through its growing global network. According to the company, this effort is also part of its larger ambition to take India-developed healthcare technology to the world. Lord’s Mark Industries Limited said it aims to make screening solutions affordable so that more women in India and abroad can access regular tests. According to the company, the initiative is intended to support greater awareness around breast cancer and highlight the role of early detection in improving treatment outcomes. The company added that it expects the product to be available for commercial use worldwide by the end of the year.For more information, see website.References: Disclaimer – The above content is non-edited, and TIL hereby disclaims any and all warranties, express or implied, relating thereto and does not warrant or necessarily endorse any content.